Studies related to Blood glucose and ECA

Ephedrine, Caffeine And Aspirin: Safety And Efficacy For Treatment Of Human Obesity

Effect None
Trial Design Double blind
Trial Length n/a
Number of Subjects 24
Sex n/a
Notes for this study:
Study conducted in 34 morbidly obese persons (BMI average 37) with 75-150mg ephedrine, 150mg caffeine, and 330mg aspirin.

2.2kg was lost over 8 weeks without any dietary restriction versus 0.7kg in placebo.

5 subjects on ECA continued for 5 months without caloric restriction (optional) and lost an additional 5.2kg, the 6th subject imposed caloric restriction and lost 66kg over a period of 13 months.

No adverse effects noted.